Share on StockTwits

Immucell Corp (NASDAQ:ICCC) Director Jonathan E. Rothschild bought 3,000 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were purchased at an average cost of $4.55 per share, for a total transaction of $13,650.00. Following the completion of the acquisition, the director now directly owns 513,436 shares in the company, valued at approximately $2,336,134. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Immucell Corp (NASDAQ:ICCC) traded up 2.20% on Friday, hitting $4.65. The stock had a trading volume of 100 shares. Immucell Corp has a 52 week low of $3.30 and a 52 week high of $5.30. The stock’s 50-day moving average is $4.62 and its 200-day moving average is $4.40. The company’s market cap is $14.1 million.

Immucell Corp (NASDAQ:ICCC) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.10) earnings per share (EPS) for the quarter. The company had revenue of $1.54 million for the quarter, compared to the consensus estimate of $1.37 million.

ImmuCell Corporation creates scientifically proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries.

Receive News & Ratings for Immucell Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immucell Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.